Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVLY
2076
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $2.46M | ﹤0.01% |
177,605
+2,600
| +1% | +$34.7K |
|
|
PRTK
2077
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $2.46M | ﹤0.01% |
+470,508
| New | +$2.09M |
|
2078
Cincinnati Financial
CINF
$26.6B
| $2.45M | ﹤0.01% |
38,300
-426,118
| -92% | -$28.1M |
|
2079
Brinker International
EAT
$10.2B
| $2.45M | ﹤0.01% |
+102,100
| New | +$2.19M |
|
|
SNCR
2080
DELISTED
Synchronoss Technologies
SNCR
| $2.45M | ﹤0.01% |
77,000
-23,078
| -23% | -$636K |
|
|
LORL
2081
DELISTED
Loral Space and Communications, Inc.
LORL
| $2.44M | ﹤0.01% |
125,100
+22,100
| +21% | +$414K |
|
|
CTIC
2082
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.44M | ﹤0.01% |
2,103,792
+17,668
| +0.8% | +$18.7K |
|
|
UBX
2083
DELISTED
Unity Biotechnology
UBX
| $2.44M | ﹤0.01% |
28,090
+13,650
| +95% | +$1.01M |
|
2084
Frequency Electronics
FEIM
$863M
| $2.43M | ﹤0.01% |
266,033
+7,900
| +3% | +$71.5K |
|
|
TESS
2085
DELISTED
Tessco Technologies Inc
TESS
| $2.43M | ﹤0.01% |
442,500
+5,500
| +1% | +$29.2K |
|
|
CTO
2086
CTO Realty Growth
CTO
$825M
| $2.43M | ﹤0.01% |
226,934
+19,738
| +10% | +$218K |
|
2087
Modine Manufacturing
MOD
$11.1B
| $2.43M | ﹤0.01% |
440,407
+107,098
| +32% | +$492K |
|
2088
GrowGeneration
GRWG
$104M
| $2.42M | ﹤0.01% |
+353,400
| New | +$1.94M |
|
2089
VanEck Semiconductor ETF
SMH
$72.4B
| $2.41M | ﹤0.01% |
+31,600
| New | +$2.17M |
|
2090
State Street Blackstone Senior Loan ETF
SRLN
$5.37B
| $2.41M | ﹤0.01% |
+55,500
| New | +$2.35M |
|
2091
Mustang Bio
MBIO
$4.5M
| $2.4M | ﹤0.01% |
1,008
-93
| -8% | -$217K |
|
|
MRC
2092
DELISTED
MRC Global
MRC
| $2.4M | ﹤0.01% |
406,900
+68,141
| +20% | +$354K |
|
2093
AmeriServ Financial
ASRV
$85M
| $2.4M | ﹤0.01% |
780,243
+9,026
| +1% | +$26.3K |
|
2094
Nelnet
NNI
$4.57B
| $2.4M | ﹤0.01% |
+50,300
| New | +$2.35M |
|
2095
Centrus Energy
LEU
$3.79B
| $2.4M | ﹤0.01% |
238,935
+132,900
| +125% | +$1.06M |
|
|
BLDP
2096
Ballard Power Systems
BLDP
$814M
| $2.4M | ﹤0.01% |
155,800
-140,613
| -47% | -$1.54M |
|
2097
McEwen Inc
MUX
$1.15B
| $2.39M | ﹤0.01% |
236,970
+58,650
| +33% | +$545K |
|
2098
ProShares Short 20+ Year Treasury ETF
TBF
$107M
| $2.39M | ﹤0.01% |
154,900
+106,300
| +219% | +$1.65M |
|
2099
WidePoint Corp
WYY
$93.4M
| $2.38M | ﹤0.01% |
341,898
+187,181
| +121% | +$1M |
|
2100
Dawson Geophysical
DWSN
$99.1M
| $2.38M | ﹤0.01% |
1,649,998
-14,384
| -0.9% | -$19.3K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.